Orthofix International (OFIX) versus Syneron Medical (ELOS) Head to Head Review

Syneron Medical (NASDAQ: ELOS) and Orthofix International (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Profitability

This table compares Syneron Medical and Orthofix International’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Syneron Medical -1.09% -1.74% -1.30%
Orthofix International 0.33% 10.26% 7.57%

Institutional & Insider Ownership

69.2% of Syneron Medical shares are owned by institutional investors. Comparatively, 94.6% of Orthofix International shares are owned by institutional investors. 5.6% of Orthofix International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Volatility & Risk

Syneron Medical has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Comparatively, Orthofix International has a beta of 0.14, suggesting that its stock price is 86% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Syneron Medical and Orthofix International, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Syneron Medical 0 1 0 0 2.00
Orthofix International 0 0 5 0 3.00

Syneron Medical presently has a consensus price target of $11.00, suggesting a potential upside of 0.00%. Orthofix International has a consensus price target of $53.30, suggesting a potential downside of 1.35%. Given Syneron Medical’s higher probable upside, equities research analysts clearly believe Syneron Medical is more favorable than Orthofix International.

Earnings and Valuation

This table compares Syneron Medical and Orthofix International’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Syneron Medical N/A N/A N/A N/A N/A
Orthofix International $409.79 million 2.40 $3.05 million $0.02 2,701.50

Orthofix International has higher revenue and earnings than Syneron Medical.

Summary

Orthofix International beats Syneron Medical on 8 of the 10 factors compared between the two stocks.

About Syneron Medical

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company’s products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.

About Orthofix International

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.

Receive News & Ratings for Syneron Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply